Efficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (PSVT).
Clinical trial NCT03464019 · TERMINATED
Trial details
- NCT number
- NCT03464019
- Sponsor
- Milestone Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-18
- Primary completion
- 2023-01-20
- Enrollment
- 1097
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.